Legacy Wealth Asset Management LLC Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Legacy Wealth Asset Management LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,336 shares of the medical equipment provider’s stock after selling 408 shares during the quarter. Intuitive Surgical makes up 0.8% of Legacy Wealth Asset Management LLC’s holdings, making the stock its 16th biggest position. Legacy Wealth Asset Management LLC’s holdings in Intuitive Surgical were worth $2,785,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. Mark Sheptoff Financial Planning LLC bought a new position in Intuitive Surgical in the 2nd quarter worth about $37,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. Finally, DT Investment Partners LLC increased its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Up 0.7 %

NASDAQ:ISRG opened at $584.08 on Friday. The company has a market capitalization of $208.04 billion, a P/E ratio of 93.90, a P/E/G ratio of 4.66 and a beta of 1.39. The business’s 50-day moving average is $538.34 and its 200 day moving average is $497.08. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $585.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 in the last three months. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ISRG shares. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Piper Sandler reiterated an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.